Variable | n (%) |
---|---|
Network affiliation (N = 494) | |
CaReNet | 217 (43.9) |
RIOS Net | 150 (30.4) |
SERCN | 31 (6.3) |
UNM Preceptor | 93 (18.8) |
Other | 3 (0.6) |
Practice type (N = 484) | |
Community health center | 184 (38.0) |
Indian Health Service | 53 (11.0) |
University faculty | 122 (25.2) |
Veterans Administration | 4 (0.8) |
Solo practitioner | 16 (3.3) |
Other group practice | 105 (21.7) |
Specialty (N = 485) | |
Family medicine | 216 (44.5) |
Pediatrics | 71 (14.6) |
Internal medicine | 81 (16.7) |
Nurse practitioners/physician assistants | 43 (8.9) |
Family medicine resident | 64 (13.2) |
Other resident | 10 (2.1) |
Years since completing primary care residency* (N = 368) | |
<10 | 139 (37.8) |
10–20 | 115 (31.2) |
>20 | 101 (27.4) |
Not applicable | 13 (3.5) |
Community Size (N = 491) | |
Town ≤25,000 people | 109 (22.2) |
Town >25,000 but <100,000 people | 60 (12.2) |
City of 100,000 to 500,000 people | 88 (17.9) |
Urban or suburban area in city of >500,000 people (not inner city) | 138 (28.1) |
Inner city, >500,000 people | 96 (19.6) |
HCV patients currently in practice (N = 491) | |
0 | 94 (19.1) |
1–5 | 180 (36.7) |
6–20 | 139 (28.3) |
>20 | 78 (15.9) |
New diagnoses of HCV during the past year† (N = 395) | |
0 | 103 (26.1) |
1–5 | 246 (62.3) |
6–15 | 34 (8.6) |
>15 | 12 (3.0) |
Prescribed antiviral therapy for HCV patients† (N = 393) | |
Yes | 72 (18.3) |
* Among physicians not currently in residency.
† Among clinicians with HCV patients in their practice.
HCV, hepatitis C; CaReNet, Colorado Research Network; RIOS Net, Research Involving Outpatient Settings Network; SERCN, Southeast Regional Clinicians’ Network; UNM, University of New Mexico.